BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1530 related articles for article (PubMed ID: 21670242)

  • 1. Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium.
    Mehran R; Rao SV; Bhatt DL; Gibson CM; Caixeta A; Eikelboom J; Kaul S; Wiviott SD; Menon V; Nikolsky E; Serebruany V; Valgimigli M; Vranckx P; Taggart D; Sabik JF; Cutlip DE; Krucoff MW; Ohman EM; Steg PG; White H
    Circulation; 2011 Jun; 123(23):2736-47. PubMed ID: 21670242
    [No Abstract]   [Full Text] [Related]  

  • 2. Bleeding Academic Research Consortium consensus report: the Food and Drug Administration perspective.
    Hicks KA; Stockbridge NL; Targum SL; Temple RJ
    Circulation; 2011 Jun; 123(23):2664-5. PubMed ID: 21670240
    [No Abstract]   [Full Text] [Related]  

  • 3. Bleeding risk of combined oral anticoagulant and antiplatelet therapy in cardiovascular disease.
    Verheugt FW
    J Cardiovasc Risk; 1996 Apr; 3(2):229-32. PubMed ID: 8836868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Combination of anticoagulants with platelet aggregation inhibitors?].
    Schieber M; Sechtem U
    Dtsch Med Wochenschr; 2005 Nov; 130(47):2725. PubMed ID: 16294291
    [No Abstract]   [Full Text] [Related]  

  • 5. [Cardiovascular diseases, antiplatelet agents, anticoagulants and hemorrhagic risk].
    Eusébio J; Reny JL; Fontana P; Nendaz M
    Rev Med Suisse; 2010 Oct; 6(267):1942, 1944-6, 1948-50. PubMed ID: 21125726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Minimizing the risks of anticoagulants and platelet inhibitors.
    Alexander KP; Peterson ED
    Circulation; 2010 May; 121(17):1960-70. PubMed ID: 20439812
    [No Abstract]   [Full Text] [Related]  

  • 7. Anticoagulants and antiplatelet therapy: 2012 update.
    Cummins D
    J Ark Med Soc; 2012 Aug; 109(2):39. PubMed ID: 22984709
    [No Abstract]   [Full Text] [Related]  

  • 8. New players in the field of antiplatelet and anticoagulant therapy in coronary heart disease - current therapeutic issues and hot topics.
    Schindler C
    Ther Adv Cardiovasc Dis; 2009 Dec; 3(6):413-21. PubMed ID: 19917636
    [No Abstract]   [Full Text] [Related]  

  • 9. Use of antiplatelet agents and anticoagulants for cardiovascular disease: current standards and best practices.
    Faxon DP
    Rev Cardiovasc Med; 2005; 6 Suppl 4():S3-14. PubMed ID: 17710074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contra: "Anti-platelet therapy is an alternative to oral anticoagulation for atrial fibrillation".
    Apostolakis S; Shantsila E; Lip GY; Lane DA
    Thromb Haemost; 2009 Nov; 102(5):914-5. PubMed ID: 19888529
    [No Abstract]   [Full Text] [Related]  

  • 11. Antithrombotic therapy in peripheral artery disease--antiplatelet therapy, anticoagulants, both or none.
    Tangelder MJ; van Hattum ES
    Thromb Haemost; 2010 Aug; 104(2):196-9. PubMed ID: 20508897
    [No Abstract]   [Full Text] [Related]  

  • 12. Atherothrombosis--wave goodbye to combined anticoagulation and antiplatelet therapy?
    Mohler ER
    N Engl J Med; 2007 Jul; 357(3):293-6. PubMed ID: 17634465
    [No Abstract]   [Full Text] [Related]  

  • 13. Risk of major bleeding with concomitant dual antiplatelet therapy after percutaneous coronary intervention in patients receiving long-term warfarin therapy.
    DeEugenio D; Kolman L; DeCaro M; Andrel J; Chervoneva I; Duong P; Lam L; McGowan C; Lee G; DeCaro M; Ruggiero N; Singhal S; Greenspon A
    Pharmacotherapy; 2007 May; 27(5):691-6. PubMed ID: 17461704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Alprostadil combined with antithrombotic drugs. Effects on hemorrhage time].
    Minciotti A; Goracci S; Nenci GG
    Minerva Cardioangiol; 1999 Dec; 47(12):651. PubMed ID: 10670245
    [No Abstract]   [Full Text] [Related]  

  • 15. Management of bleeding in patients using antithrombotic agents: prediction, prevention, protection and problem-oriented intervention.
    Scharf RE
    Hamostaseologie; 2009 Nov; 29(4):388-98. PubMed ID: 19882082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical pharmacology of antithrombotic drugs in coronary artery disease.
    Fauler J
    Ther Adv Cardiovasc Dis; 2009 Dec; 3(6):465-78. PubMed ID: 19726525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evolving antithrombotic treatment strategies for acute ST-elevation myocardial infarction.
    Kandzari DE
    Rev Cardiovasc Med; 2006; 7 Suppl 4():S29-37. PubMed ID: 17224888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiplatelet and anticoagulants drugs.
    Treat Guidel Med Lett; 2008 May; 6(69):29-36; quiz 2 p following 36. PubMed ID: 18443541
    [No Abstract]   [Full Text] [Related]  

  • 19. Subretinal hemorrhages associated with age-related macular degeneration in patients receiving anticoagulation or antiplatelet therapy.
    Kuhli-Hattenbach C; Fischer IB; Schalnus R; Hattenbach LO
    Am J Ophthalmol; 2010 Feb; 149(2):316-321.e1. PubMed ID: 19939348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The utility of cardiovascular drugs in the treatment of cerebrovascular disease.
    Bösel J; Amiri H
    Curr Opin Investig Drugs; 2010 Sep; 11(9):1015-24. PubMed ID: 20730696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 77.